A vaccine that blocks infection with the human papillomavirus has helped to lower cervical cancer rates. Researchers want to ...

Pembrolizumab (Keytruda) given before and after surgery to supplement adjuvant therapy improved responses and survival in ...

New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...

A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

A doctor at Monday’s event said some of the reasons for Iowa’s increased cancer rate include HPV, alcohol use, and the state’s higher obesity rate.

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

In an exclusive excerpt from her new book The Book of Alchemy, Suleika Jaouad reflects on how the devastating effects of the disease changed her relationship with her body.

In in vitro and in vivo preclinical studies, ficerafusp alfa + a KRAS-G12C inhibitor (G12Ci) was shown to be more effective than G12Ci alone, with G12Ci-resistant lung cancer cells remaining ...

With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain ...

Pembrolizumab combo before/after surgery and radiation significantly improved event-free survival in resectable advanced head ...